HANARO K-Beauty ETF Surpasses 22% Return in Three Months

NH-Amundi Asset Management announced on May 21 that the 'HANARO K-Beauty ETF' has surpassed a 22% return over the past three months.

According to fund evaluation firm KG Zeroin, as of May 20, the HANARO K-Beauty ETF posted returns of 10.73% over one month, 22.62% over three months, and 33.14% over six months.

The HANARO K-Beauty ETF is a product that invests across the entire K-beauty industry, including cosmetics and aesthetic medical devices. It includes not only cosmetics stocks such as Amorepacific, LG Household & Health Care, APR, and Cosmax, but also aesthetic medical device stocks such as PharmaResearch and Hugel.

Exports of domestically produced cosmetics have increased to an all-time high, and the number of medical tourists, especially those seeking skin treatments, has risen significantly.

South Korea's cumulative cosmetics exports from January to April this year reached $3.6 billion, up 16% compared to the same period last year. If this trend continues, cosmetics exports are expected to greatly surpass last year's record high.

The number of foreigners visiting dermatology clinics in South Korea is also rapidly increasing. In April, foreign medical spending in South Korea reached a record high of 187.7 billion won, with more than half of this amount spent at dermatology clinics. This trend is also reflected in first-quarter corporate earnings. PharmaResearch, a leading company in aesthetic medicine, saw its first-quarter operating profit increase by 68% year-on-year due to the popularity of 'Rejuran'.

Kim Seungcheol, Head of ETF Investment at NH-Amundi Asset Management, stated, "The HANARO K-Beauty ETF is a product that invests across the entire K-beauty industry, encompassing not only cosmetics but also aesthetic medical products such as fillers." He added, "K-beauty has established itself as a global brand not only in Asia but also in the United States, Europe, and South America, making structural growth possible."